Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471896 · ClinicalTrials.gov registry record · NA
Joovvin' for Your Skin Health Study
A NA study of Eczema and Acne, sponsored by ProofPilot.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT04471896 is a NA study of Eczema and Acne that has completed, run by ProofPilot. The registered enrollment target is 63 participants, below the 204-participant average among 29 other Eczema trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04471896, a NA study of Eczema and Acne, has completed, sponsored by ProofPilot.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
Sixty day single arm trial examining self-report and remote dermatology assessment of cosmetic skin health after daily 10-20 minute sessions with an infrared light therapy device (the Joovv Mini)
Conditions Studied
Interventions
- DEVICE Joovv Mini
Study Locations (1)
New York
- ProofPilot (Virtual Study: https://p.proofpilot.com) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2021-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471896
The ClinicalTrials.gov registry entry for NCT04471896 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 29 other Eczema trials with a reported enrollment target (69% lower). The listed sponsor is ProofPilot, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Eczema appearing as the primary indexed condition, and to 1 intervention - of which Joovv Mini is the first listed.
NCT04471896 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04471896 about?
NCT04471896 is a clinical study titled "Joovvin' for Your Skin Health Study". Sixty day single arm trial examining self-report and remote dermatology assessment of cosmetic skin health after daily 10-20 minute sessions with an infrared light therapy device (the Joovv Mini)
What is the current status of trial NCT04471896?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2020-08-01. Estimated completion is 2021-02-01.
What conditions does trial NCT04471896 study?
This clinical trial studies the following conditions: Eczema, Acne, Skin Diseases, Skin Inflammation, Skin Condition.
What interventions are being tested in trial NCT04471896?
The interventions under investigation include: Joovv Mini (DEVICE).
Who is sponsoring clinical trial NCT04471896?
This trial is sponsored by ProofPilot, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04471896 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eczema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
Infant Restore: Efficacy of Microbiome Analysis and Education
ACTIVE NOT RECRUITING · NA
-
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
COMPLETED · NA
-
Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy
COMPLETED · NA
-
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
RECRUITING · Phase 3
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.